MAPT and Alzheimer disease: Here, we utilise a post-mortem tissue cohort of non-diseased and AD cases, previously characterised for a variety of tau and Aβ species [2, 3], to contextualise the activation of the UPR and neuro-inflammation as well as associations with synaptic loss within the lateral temporal cortex.